Posts By Alex
-
673Wire StoriesBehavox Founder and CEO To Discuss Montr�al As Growing Destination for Business and Technology Industry in Upcoming Webinar
Fast-Growing AI Company Announces Erkin Adylov�s Official Relocation to Montr�al in Support of the Company�s Expansion and Investment in Canada MONTREAL–(BUSINESS WIRE)–Behavox,...
-
739Wire Stories
OmniClouds Standardizes on Versa Networks to Deliver Secure SD-WAN Across the Globe
SINGAPORE–(BUSINESS WIRE)–OmniClouds, the leading innovator in the cloud service provider (CSP) space and migrator for the EMEA region, today announced that it...
-
721Wire Stories
Osaka Matsui Management Says NVIDIA Buys Chipmaker Arm for $40 billion
OSAKA, Japan–(BUSINESS WIRE)–Analysts at Japanese financial services company Osaka Matsui Management have said that Graphics giant NVIDIA has announced its $40 billion...
-
649Wire Stories
India Micro Irrigation Systems Market to 2025: Market is Projected to Grow at a CAGR of 10.9% – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “India Micro Irrigation Systems Market – Growth, Trends, and Forecast (2020 – 2025)” report has been added to ResearchAndMarkets.com’s offering....
-
815Wire Stories
DNA Experts Gather to Advance Forensic Science at 2020 International Symposium on Human Identification
Record-setting 2200 people attending Promega-hosted virtual meeting MADISON, Wis.–(BUSINESS WIRE)–#ISHI31–An infant kidnapped from a Chicago hospital. A man who became an �unidentified...
-
635Wire Stories
Starpharma�s SPL7013 COVID-19 Nasal Spray Virucidal Against SARS-CoV-2
New data generated at Scripps Research Institute in the US shows that Starpharma�s antiviral nasal spray active (SPL7013) is virucidal, inactivating more...
-
716Wire Stories
HiFiBiO Therapeutics Announces a Global Strategic Partnership With ABL Bio for the Co-Development of a SARS-CoV-2 Neutralizing Antibody
CAMBRIDGE, Mass. & PARIS & SHANGHAI & HONG KONG–(BUSINESS WIRE)–HiFiBiO Therapeutics, a clinical-stage multinational biotherapeutics company focused on the development of novel...
-
763Wire Stories
First Patient Enrolled in AVITA Therapeutic�s Pivotal Study Evaluating the RECELL System for Repigmentation of Stable Vitiligo
VALENCIA, Calif. & MELBOURNE, Australia–(BUSINESS WIRE)–AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology...
-
745Wire Stories
Game Publisher Kwalee Continues Rapid Expansion with New Office in China
? Leading mobile game publisher Kwalee continues to grow in 2020, with the introduction of a team in China ? The new...
-
945Wire Stories
Daiichi Sankyo Initiates Phase 2 Study of Patritumab Deruxtecan in Patients with HER3 Expressing Advanced Colorectal Cancer
Phase 2 study to evaluate patritumab deruxtecan, a potential first-in-class HER3 directed antibody drug conjugate, in previously treated patients with HER3 expressing...
